Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline
Abstract Although the concentrations of Alzheimer’s disease (AD) biomarkers Aβ1–40, Aβ1–42 and tau protein are very low in human plasma, ultrasensitive assays such as immunomagnetic reduction (IMR) are able to precisely quantify them. Review articles have described the detailed working mechanism of...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Adis, Springer Healthcare
2020-10-01
|
| coleção: | Neurology and Therapy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s40120-020-00215-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|